The use of antioxidant supplements in coronary heart disease (Q34805200)

4 August 2017

1 reference

title

The use of antioxidant supplements in coronary heart disease (English)

1 reference

4 August 2017

main subject

coronary artery disease

1 reference

2

Roland Stocker

1 reference

4 August 2017

Leonard Kritharides

1

1 reference

4 August 2017

publication date

1 October 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

164

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

211-219

1 reference

The role of oxidized lipoproteins in atherogenesis

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

A critical look at the evidence for the oxidation of LDL in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Dietary and pharmacological antioxidants in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Metabolism of oxidized LDL by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Tea flavonols in cardiovascular disease and cancer epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Vitamin E consumption and the risk of coronary disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Vitamin E consumption and the risk of coronary heart disease in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Effects of vitamin E on lipid peroxidation in healthy persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Human Atherosclerotic Plaque Contains Both Oxidized Lipids and Relatively Large Amounts of α-Tocopherol and Ascorbate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Indices of lipid peroxidation in vivo: strengths and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

In Vivo Formation of 8-Epi-Prostaglandin F 2α Is Increased in Hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Modulation of oxidant stress in vivo in chronic cigarette smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Dietary antioxidants and carotid artery wall thickness. The ARIC Study. Atherosclerosis Risk in Communities Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Effect of Vitamin E and Beta Carotene on the Incidence of Primary Nonfatal Myocardial Infarction and Fatal Coronary Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Do vitamin E and fish oil protect against ischaemic heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Vitamin E supplementation and cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Water soluble vitamins in chronic hemodialysis patients and need for supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Lipophilic antioxidants and iron status in ESRD patients on hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Lowering of HDL 2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With Hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasison vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Site-specific antiatherogenic effect of probucol in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Oxidants and antioxidants in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Vitamin E oxidation in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

Vitamin E and vascular homeostasis: implications for atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(02)50011-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(02)00011-4

1 reference

4 August 2017

1 reference